[Vanishing prostate cancer. Clinical presentation and histological review]

Actas Urol Esp. 2009 Oct;33(9):956-9. doi: 10.1016/s0210-4806(09)72893-1.
[Article in Spanish]

Abstract

The impossibility to identify cancer in the final surgical specimen has been reported in some patients with prostate cancer undergoing radical prostatectomy. This has been attributed to either a wrong diagnosis or pathological technique, or to spontaneous or biopsy-induced cure of the tumor. This study assessed the incidence of vanishing prostate cancer in our department for 12 years, the clinical characteristics of patients, and their follow-up. The initial puncture biopsies were also re-evaluated using inmunohistochemical stains. Prostate cancer could not be confirmed in the surgical specimen in six out of 346 operated patients (1.73%) receiving no neoadjuvant therapy. When the initial biopsies were reviewed, cancer was only confirmed in three patients. Incidence of vanishing cancer at our department in the 12-year period considered was 0.86% (3/346). No tumor relapse occurred during 4.5 years of follow-up.

Publication types

  • English Abstract

MeSH terms

  • Biopsy, Needle
  • Humans
  • Male
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / pathology*